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Abstract
Background:  Clinically  signiﬁcant  macular  oedema  has  features  that  are  associated  with  a  major
risk of  visual  loss,  with  thickening  that  involves  the  centre  of  the  macula,  ﬁeld  7  or  visual
deﬁciency,  although  it  is  unknown  if  these  features  are  related  to  retinal  thickness  extension.
Material  and  methods:  An  observational,  analytical,  prospective,  cross-sectional  and  open
study was  conducted.  The  sample  was  divided  into  initial  visual  acuity  ≥0.5,  central  ﬁeld  thick-
ness, centre  point  thickness,  ﬁeld  7  and  macular  volume  more  than  the  reported  2  standard
deviation  mean  value  in  eyes  without  retinopathy.  The  extension  was  determined  by  the  number
of the  central  ﬁeld  area  equivalent  thickening  and  these  features  were  compared  by  Student’s
t test  for  independent  samples.
Results:  A  total  of  199  eyes  were  included.  In  eyes  with  visual  acuity  of  ≥0.5,  the  mean  exten-
sion was  2.88  ±  1.68  and  3.2  ±  1.63  in  area  equivalent  in  eyes  with  visual  acuity  <0.5  (p  =  0.12).
The mean  extension  in  eyes  with  less  than  2  standard  deviation  of  central  ﬁeld  thickness,  cen-
tre point  thickness,  ﬁeld  7  and  macular  volume  was  signiﬁcantly  lower  than  in  eyes  with  more
than 2  standard  deviations  (1.9  ±  0.93  vs.  4.07  ±  1.49,  2.44  ±  1.47  vs.  3.94  ±  1.52,  1.79  ±  1.07
vs. 3.61  ±  1.57  and  1.6  ±  0.9  vs.  3.9  ±  1.4,  respectively,  p  <  0.001).
Conclusions:  The  extension  of  retinal  thickness  is  related  with  the  anatomical  features  reported
with a  greater  risk  of  visual  loss,  but  is  not  related  to  initial  visual  deﬁciency.
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Características  relacionadas  con  la  extensión  del  engrosamiento  retiniano  en  edema
macular  diabético
Resumen
Antecedentes:  El  edema  macular  clínicamente  signiﬁcativo  presenta  características  asociadas
con mayor  riesgo  de  pérdida  visual:  engrosamiento  que  involucra  el  centro  de  la  mácula,  el
campo 7  o  baja  visual  inicial;  sin  embargo,  se  desconoce  la  relación  entre  estas  características
y la  extensión  del  engrosamiento  retiniano.
Material  y  métodos:  Estudio  observacional,  analítico,  prospectivo,  transversal  y  abierto.  La
muestra se  dividió  en  función  de  la  capacidad  visual  inicial  ≥  o  <  0.5,  grosor  del  campo  central,
del punto  central,  campo  7  y  volumen  macular  >  2  desviaciones  estándar  del  promedio  reportado
en ojos  sin  retinopatía.  La  extensión  se  determinó  mediante  el  número  de  equivalentes  de  área
del campo  central  engrosados,  y  se  comparó  con  las  características  mediante  la  t  de  Student
para medias  independientes.
Resultados:  Ciento  noventa  y  nueve  ojos  incluidos.  En  ojos  con  capacidad  visual  ≥  0.5  el  prome-
dio de  extensión  fue  2.88  ±  1.68  y  3.2  ±  1.63  equivalentes  de  área  en  ojos  con  <  0.5  (p  =  0.12).
El promedio  de  extensión,  en  ojos  con  menos  de  2  desviaciones  estándar  del  grosor  del  campo
central, punto  central,  campo  7  y  volumen  macular  fue  signiﬁcativamente  menor  a  los  ojos
con más  de  2  desviaciones  estándar  (1.9  ±  0.93  vs.  4.07  ±  1.49,  2.44  ±  1.47  vs.  3.94  ±  1.52,
1.79 ±  1.07  vs.  3.61  ±  1.57  y  1.6  ±  0.9  vs.  3.9  ±  1.4,  respectivamente,  p  <  0.001).
Conclusión:  La  extensión  del  engrosamiento  retiniano  se  relaciona  con  las  características
anatómicas  reportadas  con  mayor  riesgo  de  pérdida  visual,  pero  no  se  relaciona  con  la  baja
visual inicial.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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with  a fast  macular  map  and  record  of  the  best-correctedackground
he  diagnosis  of  clinically  signiﬁcant  macular  oedema  is
ased  on  characteristics  related  to  a  greater  risk  of  devel-
ping  moderate  vision  loss,  regardless  of  the  degree  of
etinopathy  at  the  time  of  diagnosis.1 The  prevalence  of  clin-
cally  signiﬁcant  macular  oedema  amounts  to  approximately
3%  in  the  Mexican  population.2
The  characteristics  described  by  the  Early  Treatment  Dia-
etic  Retinopathy  Study  (ETDRS)  are  the  following:  retinal
hickening  in  the  centre  of  the  macula  or  within  500  microns
f  the  adjacent  retina;  presence  of  exudate  in  the  centre  of
he  macula  or  within  500  microns  of  the  adjacent  retina,
f  associated  with  the  thickening  of  the  adjoining  retina;
r  the  presence  of  retinal  thickening  in  an  area  (or  areas)
arger  than  a  disc  area,  located  at  a  distance  amounting  to
he  diameter  of  a  disc  or  less  in  relation  to  the  centre  of  the
acula.3
Another  characteristic  not  included  by  the  ETDRS,  but
hich  has  been  reported  as  associated  with  a  greater  risk
f  vision  loss,  is  the  thickening  involving  or  surrounding  the
entre  of  the  fovea4 and  affecting  the  temporal  perifoveal
eld.5
Several  studies  have  reported  on  the  relation  between
natomical  characteristics,  such  as  the  central  point  thick-
ess  or  the  macular  volume,  and  functional  characteristics,
uch  as  visual  capacity,  and  have  determined  that  the  corre-
ation  between  these  is  highly  variable.6--9 However,  studies
ave  not  taken  into  account  the  extension  of  the  oedema
resent  in  these  patients.  The  use  of  optical  coherence
v
somography  has  allowed  for  the  objective  assessment  of  the
edema  pattern  (focal  or  diffuse)10 and  for  the  determina-
ion  of  the  amount  of  ﬁelds  affected  by  the  thickening.11
The  optical  coherence  tomography  and  the  macular  vol-
me  allowed  for  the  determination  of  the  affected  area
efore  photocoagulation  and  its  relation  to  the  characteris-
ics  associated  with  the  risk  of  vision  loss,  so  as  to  assess  if
esult  variability  is  related  to  the  extension  of  the  oedema
nd  not  only  to  its  characteristics.
aterial and methods
n  observational,  analytical,  prospective,  cross-sectional
nd  open  study  was  conducted  in  type  2  diabetic  patients
ith  clinically  signiﬁcant  macular  oedema  in  Mexico  City
nd  its  metropolitan  area.  The  sample  was  obtained  from
atients  who  attended  Hospital  Juárez  de  México,  from  1
ay  2008  to  31  July  2014.  The  study  began  on  1 January  and
nded  on  31  August  2014.  It  was  authorised  by  the  research
nd  research  ethics  committees  of  the  hospital  in  which  it
as  conducted.  All  patients  agreed  to  participate  in  the
tudy  by  giving  their  written  consent.
The  study  included  type  2  diabetic  patients  from  40  to
0  years  old,  of  either  gender,  with  any  degree  of  diabetic
etinopathy  and  focal  clinically  signiﬁcant  macular  oedema,isual  acuity  on  the  day  of  the  treatment.
The  following  subjects  were  excluded  from  the  study:
ubjects  with  opacity  of  mean  limiting  visual  function  per
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(Extension  of  retinal  thickness  in  diabetic  macular  edema  
se  (cataract,  preretinal  haemorrhage),  thickened  poste-
rior  vitreous,  ﬂuorescein  angiography  ischaemia,  other  ma-
culopathy  or  retinopathy,  eyes  previously  treated  with  focal
photocoagulation  and  measurement  errors  in  the  fast  mac-
ular  map  (any  deviation  from  the  line  of  optical  coherence
tomography  compared  to  the  actual  limit  of  the  retina).
Only  one  researcher  diagnosed  a  patient  with  clinically
signiﬁcant  macular  oedema,  according  to  the  criteria  of
the  ETDRS.  The  best-corrected  visual  acuity  was  measured
under  refraction,  with  eye  charts  from  the  ETDRS.  All  fast
macular  maps  were  obtained  under  mydriasis  ≥  6  mm,  using
the  optical  coherence  tomography  equipment  Stratus® (Carl
Zeiss  Meditec,  Inc.,  Dublin,  California,  USA,  software  version
4.01),  applying  the  following  standardised  procedure:  spher-
ical  equivalent  inclusion,  identiﬁcation  of  the  retinal  plane
with  an  acoustic  alert,  scan  for  dark  eye  and  optimisation  of
polarisation  and  z-axis.  The  maps  were  obtained  using  ﬂash,
between  9:00  and  11:00  a.m.12,13 To  ensure  that  these  were
centred,  veriﬁcation  was  obtained  that  the  thinnest  area
was  included  within  the  central  circle  and  that  the  rela-
tion  between  the  standard  deviation  of  the  central  point
thickness  and  the  central  point  thickness  was  lower  than
10%.14
The  sample  was  divided  according  to  the  characteris-
tics  identiﬁed  as  associated  with  vision  loss:  best-corrected
visual  acuity  <  20/40,  central  ﬁeld  thickening,  temporal  per-
ifoveal  ﬁeld  thickening  and  volume.  The  deﬁnition  of  central
thickening,  temporal  perifoveal  thickening  and  volume  was
the  value  of  each  of  these  exceeding  by  more  than  2  standard
deviations  the  mean  found  for  this  value  in  eyes  without
retinopathy.
The  study  variable  was  the  total  extension  of  the  thicken-
ing,  which  was  deﬁned  according  to  the  number  of  thickened
ﬁelds  as  follows:  each  thickened  ﬁeld  observed  in  the  opti-
cal  coherence  tomography  was  identiﬁed  (the  value  of  each
ﬁeld  exceeding  by  more  than  2  standard  deviations  the  mean
of  the  retinal  thickness  found  in  eyes  without  retinopathy  in
the  fast  macular  map).  The  conversion  of  central  ﬁeld  equiv-
alent  areas  was  performed  (1000  microns  in  diameter)  based
on  the  following:  ﬁeld  1  --  one  area  of  central  ﬁeld;  ﬁelds
2,  3,  4  and  5  --  0.5  areas  of  central  ﬁeld;  ﬁelds  6,  7,  8  and
9  --  0.75  areas  of  central  ﬁeld.  These  equivalent  areas  were
added  up  to  obtain  the  total  extension  of  the  thickening.
The  mean  total  extension  was  compared  among  related
characteristics  using  the  Student’s  t-test  for  independent
mean  values.
The  following  value  was  considered  signiﬁcant:  p  <  0.05.
Data  were  collected  and  analysed  using  the  software
Minitab,  version  16.
Results
The  study  assessed  199  eyes  from  154  type  2  diabetic
patients,  from  41  to  78  years  old  (average  of  58.47,
standard  deviation  [SD]  ±  9.28),  of  which  119  eyes  belonged
to  female  subjects  (59.8%).  The  progression  of  diabetes
ranged  from  1  to  30  years  (average  of  14.56  SD  ±  6.78),
and  86  patients  were  treated  with  oral  hypoglycaemi-
ants  (55.9%)  and  34  patients  were  treated  with  insulin
(22%).  Average  fasting  blood  sugar  levels  amounted  to
176.81  SD  ±  87.05  mg/dl;  average  glycosylated  haemoglobin
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mounted  to  10.8  SD  ±  4.04%;  average  cholesterol  amounted
o  206.4SD  ±  62.01  mg/dl;  average  triglycerides  amounted
o  172.08  SD  ±  93.4  mg/dl;  average  creatinine  clearance
mounted  to  46.9  SD  ±  30.78  mg/dl.  Average  systolic  blood
ressure  amounted  to  140.8  SD  ±  21.6  mm  Hg;  average  dia-
tolic  blood  pressure  amounted  to  84.46  SD  ±  12.15  mm  Hg;
nd  mean  blood  pressure  amounted  to  103.03  SD  ±  14.58  mm
g.
Seventy  patients  suffered  from  high  blood  pressure
44.4%);  48  of  these  patients  were  treated  with  angiotensin
onverting  enzyme  inhibitors  (31.1%).  As  to  the  degree  of
etinopathy:  14  patients  presented  mild  non-proliferative
etinopathy  (7%);  107  patients  presented  moderate  non-
roliferative  retinopathy  (53.8%);  12  patients  presented
evere  non-proliferative  retinopathy  (6%);  and  66  patients
resented  proliferative  retinopathy  (33.2%).  One  hundred
nd  twenty-four  patients  presented  monofocal  oedema
62.3%)  and  75  patients  presented  multifocal  oedema
37.7%).  There  were  no  differences  among  the  different
egrees  of  retinopathy  and  the  thickening  extension,  the
nitial  vision  loss,  and  the  central  ﬁeld  and  central  point
hickening  (p  > 0.5).
The  location  of  the  oedema  was  superotemporal  in  103
yes  (28.9%),  inferior  in  102  eyes  (28.6%),  temporal  in  30
yes  (8.4%),  superior  in  27  eyes  (7.6%),  nasal  in  27  eyes
7.6%),  superonasal  in  24  eyes  (6.7%),  inferotemporal  in  9
yes  (2.5%)  and  inferonasal  in  8  eyes  (2.2%).
The  initial  visual  capacity  ranged  from  0.15  to  1.00  dec-
mal  equivalents,  with  an  average  of  0.46  ±  0.26.  The  aver-
ge  central  ﬁeld  amounted  to  217.7  m  ±  33.2;  the  average
entral  point  thickness  amounted  to  184.6  m  ±  33.9;  and
he  average  macular  volume  amounted  to  7.99  mm3 ±  0.65.
The  total  extension  ranged  from  0.5  to  6  area  equiv-
lents,  with  an  average  of  3.08  ±  1.66.  In  eyes  with
isual  capacity  ≥  0.5  (≥20/40,  n  =  92),  the  average  exten-
ion  was  2.88  ±  1.68  area  equivalents,  while  in  eyes  with
isual  capacity  <0.5  (<20/40),  the  average  extension  was
.2  ±  1.63  area  equivalents  (p  =  0.12).  The  central  ﬁeld
hickness  lower  than  2  SD  (n  =  91)  presented  an  aver-
ge  extension  of  1.9  ±  0.93  area  equivalents,  while  the
entral  ﬁeld  thickness  greater  than  2  SD  (n  =  108)  pre-
ented  an  average  extension  of  4.07  ±  1.49  area  equivalents
p  <  0.001).
The  central  ﬁeld  thickness  lower  than  2  SD  (n  =  114)
resented  an  average  extension  of  2.44  ±  1.47,  while  the
entral  ﬁeld  thickness  greater  than  2  SD  (n  =  85)  pre-
ented  an  average  extension  of  3.94  ±  1.52  area  equivalents
p  <  0.001).
Field  7  with  a  thickness  lower  than  2  SD  (n  =  58)  presented
n  average  extension  of  1.79  ±  1.07,  while  ﬁeld  7  with  a
hickness  greater  than  2  SD  (n  =  141)  presented  an  average
xtension  of  3.61  ±  1.57  area  equivalents  (p  <  0.001).
The  normal  macular  volume  (n  =  71)  presented  an  average
xtension  of  1.6  ±  0.9  area  equivalents,  while  the  macular
olume  with  a  thickness  greater  than  2  SD  (n  =  128)  pre-
ented  an  average  extension  of  3.9  ±  1.4  area  equivalents
p  <  0.001).
As  to  only  the  extension  of  ﬁeld  1,  there  were  108  eyes
ith  thickening  greater  than  2  SD  (54.3%);  the  internal  ring
as  affected  in  135  cases  (67.8%)  in  one  or  more  correspond-
ng  ﬁelds;  and  the  external  ring  was  affected  in  186  cases
93.5%)  in  one  or  more  ﬁelds  (Table  1).
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Table  1  Distribution  of  ﬁelds  with  thickening  greater  than  2  standard  deviations  in  each  ﬁeld  of  the  optical  coherence
tomography.
Average  thickness  ±  SD  Eyes  with  thickness  ≥  2SD  95%  CI
Lower  limit  Upper  limit
Field  1  217.7  ±  33.2  108  (54.3%)  47.38  61.22
Field 2  298.9  ±  36.3  83  (41.7%)  34.85  48.55
Field 3 291.1  ±  38.1 101  (50.8%)  43.85  57.75
Field 4 284.1  ±  31.9 47  (23.6%) 17.70  29.50
Field 5 285.7  ±  31 50  (25.1%) 19.08 31.12
Field 6 293.2  ±  39.2 133  (66.8%) 60.26 73.34
Field 7  279.68  ±  40.2  141  (70.9%)  64.59  77.21
Field 8  269.8  ±  33.8  113  (56.8%)  49.92  63.68
Field 9  289.4  ±  33.9  100  (50.3%)  43.35  57.25
CPT 184.6  ±  33.9  85  (42.7%)  35.83  49.57
Macular volume 7.99  ±  0.65 128  (64.3%) 57.64 70.96
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RSD, standard deviation; CPT, central point thickness; 95% CI, 95% 
iscussion
he  extension  of  the  thickening  was  not  related  to  vision
oss  prior  to  treatment  (p  <  0.05).  Some  studies  have  demon-
trated  that,  although  visual  acuity  is  the  standard  for
unctional  assessment  in  patients  with  diabetic  retinopa-
hy,  it  may  not  be  the  best  tool  for  its  assessment  in
hese  patients,  given  that  their  correlation  with  anatom-
cal  changes  is  modest.6,15--17 There  are  other  tools  that
elp  in  the  assessment  of  the  visual  function,  such
s  microperimetry17,18 or  electroretinography,19,20 which
equire  further  studies  to  analyse  the  association  between
he  extension  of  the  oedema  and  the  visual  dysfunction
resent  in  these  patients.
The  anatomical  characteristics  that  have  demonstrated
o  be  associated  with  a  higher  risk  of  vision  loss  are  areas
ith  greater  thickness,  such  as  the  following:  the  central
eld,1 the  temporal  perifoveal  ﬁeld  (ﬁeld  7),5 the  cen-
ral  point  and  the  macular  volume.21 In  this  study,  these
haracteristics  were  signiﬁcantly  associated  with  a  greater
xtension  of  the  thickening,  as  they  presented  an  almost
wo-times  larger  extension  when  affected.  The  diabetic
etinopathy  clinical  research  network  found  a  low  corre-
ation  between  the  number  of  thickened  ﬁelds  prior  to
reatment  and  visual  acuity  (r  =  0.38),  and  a  good  correla-
ion  between  the  number  of  thickened  ﬁelds  and  the  central
eld  and  macular  volume  (0.64  and  0.77,  respectively).22
Browning  et  al.10 have  outlined  the  need  to  identify  the
haracteristics  of  the  macular  oedema  beyond  the  stan-
ardised  classiﬁcation,  such  as  the  thickening  extension  and
ocation,  the  affection  or  lack  of  affection  of  the  centre  of
he  macula,  among  others.  The  determination  of  the  thick-
ning  extension  and  its  relation  to  the  characteristics  that
avour  vision  loss  establish  a  cut-off  point  to  understand  the
ondition  of  the  affected  eye.  However,  the  extension  does
ot  itself  justify  the  functional  condition  of  the  eye.
It  has  been  reported  that  retinal  dysfunction  appears
efore  the  occurrence  of  anatomical  changes  and  visual
cuity  reduction.  Therefore,  other  factors  that  may
e  contributing  to  neural  dysfunction,  apart  from  the
hickening.23,24dence intervals.
The  optical  coherence  tomography  is  still  a  useful  tool  for
he  assessment  of  the  condition  and  follow-up  of  patients
ith  macular  oedema.25 The  identiﬁcation  of  thickening
reas  and  its  extension  would  allow  for  the  identiﬁcation  of
haracteristics  that  could  be  involved  in  patients’  prognosis.
nderstanding  the  thickening  extension  and  its  modiﬁca-
ions  after  treatment  could  help  to  explain  the  different
esults  obtained  from  patients  and,  thus,  to  identify  the
haracteristics  related  to  the  worst  prognosis.
onclusion
he  extension  of  the  retinal  thickening  is  related  to  anatom-
cal  characteristics  reported  as  with  greater  risk  of  vision
oss  in  patients  with  macular  oedema.  However,  the  exten-
ion  does  not  itself  explain  the  presence  of  low  visual  acuity
t  the  moment  of  treatment.
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